RWE FDA Regulatory Submission Guide: What FDA and EMA Now Accept as Real-World Evidence for Drug Approval and Label Expansion
In December 2025, the FDA announced it was eliminating a major barrier to using real-world evidence in drug and device
How to Make the Case for RWE Investment Internally: A Guide to Pharma Data Procurement, GDPR Compliance and Stakeholder Buy-In
Here’s a scenario that will feel uncomfortably familiar to anyone who has tried to initiate a real-world data programme inside
Pharma Competitive Intelligence with Real-World Evidence: Tracking Competitor Treatment Patterns, Prescribing Shifts and Real-World Market Share
The Intelligence Gap That’s Costing Brand Teams Strategic Ground Here’s a scenario that plays out more often than anyone in
Why Pharma Launches Fail: How Real-World Data Exposes the Market Sizing, Patient Journey and Payer Uptake Gaps Behind Failed Drug Launches
Here’s a number that should make any launch team uncomfortable: more than half of all pharma launches miss their commercial